학술논문
Phase II Study of Taselisib in PIK3CA Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCIMATCH ECOG-ACRIN Trial (EAY131) Subprotocol I
Document Type
Article
Author
Krop, I.E.; Jegede, O.A.; Gray, R.J.; Wang, V.; Grilley-Olson, J.E.; Lauring, J.D.; Mitchell, E.P.; Zwiebel, J.A.; McShane, L.M.; Rubinstein, L.V.; Patton, D.; Conley, B.A.; Harris, L.N.; Chen, A.P.; Mickey Williams, P.; Hamilton, S.R.; Kono, S.A.; Ford, J.M.; Garcia, A.A.; Sui, X.D.; Siegel, R.D.; Slomovitz, B.M.; Arteaga, C.L.; O'Dwyer, P.J.; Flaherty, K.T.
Source
In: JCO Precision Oncology . (JCO Precision Oncology, 2022, 6)
Subject
Language
English
ISSN
24734284